Amanda Psyrri

National and Kapodistrian University of Athens — Greece

Medicine · Health Sciences

58h-index18.2kcitations601works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(179), Cancer Immunotherapy and Biomarkers(134), Lung Cancer Treatments and Mutations(114), Cancer Genomics and Diagnostics(78), PARP inhibition in cancer therapy(67)

Publications596 total

Real World Data from Patients With Osteosarcoma Treated in 8 Medical Centers in Greece: Ninety Percent or Greater Tumor Necrosis Is Associated With Disease‐free Survival
Cancer Diagnosis & Prognosis·2025· 1 citedOpen Access
Advances in Prevention, Screening, and Early Detection of HPV-Associated Head and Neck Cancers
Viruses·2025Open Access
Deciphering site‑specific histopathological parameters with potential clinical value in head and neck squamous cell carcinomas
Oncology Letters·2025Open Access
EP.01.19 Characteristics of Lung Cancer in Never- and Light-Smokers: A Retrospective Study From Greece
Journal of Thoracic Oncology·2025
The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity
Biomedicines·2025Open Access
Invasive Lobular Carcinoma Metastasis to the Female Genital Tract: A Systematic Search and Review of Case Reports and Case Series
Diagnostics·2025· 2 citedOpen Access
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study
Journal of Clinical Oncology·2025· 7 citedOpen Access
1348MO SKYSCRAPER-09: Phase II, randomised study of tiragolumab (tira) + atezolizumab (atezo) and atezo + placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/metastatic PD-L1+ squamous cell carcinoma of the head and neck (R/M SCCHN)
Annals of Oncology·2025
Invasive Lobular Carcinoma Metastases to the Female Genital Tract. A Review of Case Reports and Case Series
Preprints.org·2025Open Access
Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study
Cancers·2025Open Access
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study
European Journal of Cancer·2025· 1 cited
Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025Open Access
Data from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025Open Access
Abstract P3-10-02: Real-world study of Abemaciclib in Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: a Multi-Institutional Prospective Study
Clinical Cancer Research·2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC
Future Oncology·2025· 3 citedOpen Access
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
Journal of Clinical Oncology·2025· 37 cited
Late toxicities (LT) in patients affected by locally advanced (LA) oropharyngeal carcinoma (OPC) treated with definitive (chemo)radiotherapy (C)RT: Risk factors and pattern of adverse effects.
Journal of Clinical Oncology·2025
Screening of TROP2, Nectin-4, and HER2 in osteosarcomas: In pursuit of a target.
Journal of Clinical Oncology·2025
SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced non-small cell lung cancer (NSCLC)—Final results.
Journal of Clinical Oncology·2025
Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma
British Journal of Cancer·2025· 4 citedOpen Access
page 1 of 30Next →

Frequent Co-authors

Clarence T. Sasaki(10), Panagiota Economopoulou(10), David L. Rimm(9), Dimitrios Pectasides(8), Barbara Burtness(7), Paul Weinberger(7), Kevin J. Harrington(6), Makoto Tahara(6), Gilberto de Castro(6), Danny Rischin(6), Ziwei Yu(6), Robert L. Camp(6), George Fountzilas(6), Theofanis Economopoulos(6), Richard Greil(5), Denis Soulières(5), Thorsten Fuereder(5), Ricard Mesı́a(5), Bruce G. Haffty(5), Diane Kowalski(5)